Sign In
Buy MYL
$15.86
+0 (+0%)
At Close: May 27, 2022
Revance And Mylan To Advance Development Program For Biosimilar To BOTOX; $30M Milestone Payable To Revance From Mylan
12:34pm, Monday, 01'st Jun 2020Revance and Mylan to Advance Development Program for Biosimilar to BOTOX®
12:30pm, Monday, 01'st Jun 2020
Revance and Mylan to Advance Development Program for Biosimilar to BOTOX®
Mylan's Pakistan Partner AGP to Sell Remdesivir to Treat Covid-19 Within Two Months
12:00am, Sunday, 31'st May 2020Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings
07:24pm, Friday, 29'th May 2020
Mylan N.V. (NASDAQ: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review (IPR) proceedings finding all challenged claims of Sa
Here is How Hedge Funds Traded Mylan N.V. (MYL) Recently
03:32pm, Friday, 29'th May 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
Statement Pursuant to Section 19(a) of the Investment Company Act of 1940: DEX
03:29pm, Friday, 29'th May 2020
On May 29, 2020, Delaware Enhanced Global Dividend and Income Fund (NYSE: DEX) (the "Fund"), a closed-end fund, paid a monthly distribution on its common stock of $0.0714 per share to shareholders of
Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents In IPR Proceedings
12:00am, Friday, 29'th May 2020Week In Review: How Trump's Policies Moved Stocks - Saturday, May 23
12:00am, Saturday, 23'rd May 2020Top Research Reports for Intel, Adobe & AMD
01:13pm, Friday, 22'nd May 2020
Top Research Reports for Intel, Adobe & AMD
Delaware Enhanced Global Dividend and Income Fund Appoints Allan Saustrup Jensen as Co-Manager
08:38pm, Tuesday, 19'th May 2020
Today, Delaware Enhanced Global Dividend and Income Fund (NYSE: DEX) (the "Fund"), a New York Stock Exchange–listed closed-end fund trading under the symbol "DEX," announced that, effective May 19,
In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs
01:38pm, Tuesday, 19'th May 2020Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; on review for downgrade
03:52pm, Monday, 18'th May 2020
Moody's Investors Service ("Moody's") assigned an A1 rating to the new senior unsecured notes being issued by Pfizer Inc. ("Pfizer"). This rating is on review for downgrade, consistent with other sen
Better Buy: Pfizer vs. Bristol Myers Squibb
06:03pm, Sunday, 17'th May 2020
Pfizer (NYSE: PFE) will look like a much different company within a few months as it spins off Upjohn and merges the unit with Mylan. Bristol Myers Squibb (NYSE: BMY) is still integrating Celgene af
